PGF and breast cancer: By analyzing levels of circulating angiogenic factors in pregnant women with BC treated with doxorubicin- and taxane-based chemotherapy regimens, it was evident that at the end of the third trimester, women with BC had significantly higher levels of sFlt-1 and ratios of sFlt-1/PlGF compared to the control group.